Pharmacological approach to wheezing in preschool children

Bibliography

• Brand PL, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008;32:1096-110
   PubMed Web of Science ®Google Scholar
• Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:133-8
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Szefler S. Prevalence of asthma-like symptoms in young children. Pediatr Pulmonol 2007;42:723-8
   PubMed Web of Science ®Google Scholar
• Bhatt JM, Smyth AR. The management of pre-school wheeze. Paediatr Respir Rev 2011;12:70-7
   PubMed Web of Science ®Google Scholar
• Papadopoulos NG, Christodoulou I, Rohde G, et al. Viruses and bacteria in acute asthma exacerbations -- a GA² LEN-DARE systematic review. Allergy 2011;66:458-68
   PubMed Web of Science ®Google Scholar
• Principi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections. Lancet Infect Dis 2001;1:334-44
   PubMedGoogle Scholar
• Lowe LA, Simpson A, Woodcock A, et al. Wheeze phenotypes and lung function in preschool children. Am J Resp Crit Care Med 2005;171:231-7
   PubMed Web of Science ®Google Scholar
• Moeller A, Diefenbacher C, Lehmann A, et al. Exhaled nitric oxide distinguishes between subgroups of preschool children with respiratory symptoms. J Allergy Clin Immunol 2008;121:705-9
   PubMed Web of Science ®Google Scholar
• Brussee JE, Smit HA, Kerkhof M, et al. Exhaled nitric oxide in 4-year-old children: relationship with asthma and atopy. Eur Respir J 2005;25:455-61
   PubMed Web of Science ®Google Scholar
• Saglani S, Payne DN, Zhu J, et al. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med 2007;176:858-64
   PubMed Web of Science ®Google Scholar
• Carraro S, Rezzi S, Reniero F, et al. Metabolomics applied to exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2007;175:986-90
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Dawson C, Weiss S. Relationships between duration of asthma and asthma severity among children in the childhood asthma management program (CAMP). J Allergy Clin Immunol 1999;103:376-87
   PubMed Web of Science ®Google Scholar
• Pérez-Yarza EG, Moreno A, Lázaro P, et al. The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature. Pediatr Infect Dis J 2007;26:733-9
   PubMed Web of Science ®Google Scholar
• O'Callaghan-Gordo C, Bassat Q, Díez-Padrisa N, et al. Lower respiratory tract infections associated with rhinovirus during infancy and increased risk of wheezing during childhood. A cohort study. PLoS One 2013;8:e69370
   Google Scholar
• Henderson J, Granell R, Heron J, et al. Associations of wheezing phenotypes in the first 6 years of life with atopy, lung function and airway responsiveness in mid-childhood. Thorax 2008;63:974-80
   PubMed Web of Science ®Google Scholar
• Duchrame FM, Krajinovic M. Steroid responsiveness and wheezing phenotypes. Pediatr Respir Rev 2011;12:170-6
   PubMedGoogle Scholar
• Smith M, Iqbal S, Elliott TM, et al. Corticosteroids for hospitalised children with acute asthma. Cochrane Database Syst Rev 2003;(2):CD002886
   Google Scholar
• Panickar J, Lakhanpaul M, Lambert PC, et al. Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med 2009;360:329-38
   PubMed Web of Science ®Google Scholar
• Vuillermin PJ, South M, Carlin JB, et al. Parent-initiated oral corticosteroid therapy for acute asthma: a survey of current practice. J Paediatr Child Health 2007;43:443-5
   PubMedGoogle Scholar
• Oommen A, Lambert PC, Grigg J. Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet 2003;362:1433-8
   PubMed Web of Science ®Google Scholar
• Schultz A, Brand PL. Phenotype-directed treatment of pre-school-aged children with recurrent wheeze. J Paediatr Child Health 2012;48:E73-8
   PubMed Web of Science ®Google Scholar
• Jartti T, Lehtinen P, Vanto T, et al. Efficacy of prednisolone in children hospitalized for recurrent wheezing. Pediatr Allergy Immunol 2007;18:326-34
   PubMed Web of Science ®Google Scholar
• Bülow SM, Nir M, Levin E, et al. Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants. Pediatrics 1999;104:e77
   PubMed Web of Science ®Google Scholar
• Jartti T, Söderlund-Venermo M, Allander T, et al. No efficacy of prednisolone in acute wheezing associated with human bocavirus infection. Pediatr Infect Dis J 2011;30:521-3
   PubMedGoogle Scholar
• Lukkarinen M, Lukkarinen H, Lehtinen P, et al. Prednisolone reduces recurrent wheezing after first rhinovirus wheeze: a 7-year follow-up. Pediatr Allergy Immunol 2013;24:237-43
   PubMed Web of Science ®Google Scholar
• Jartti T, Kuusipalo H, Vuorinen T, et al. Allergic sensitization is associated with rhinovirus-, but not other virus-, induced wheezing in children. Pediatr Allergy Immunol 2010;21:1008-14
   PubMed Web of Science ®Google Scholar
• Jartti T, Lehtinen P, Vanto T, et al. Atopic characteristics of wheezing children and responses to prednisolone. Pediatr Pulmonol 2007;42:1125-33
   PubMedGoogle Scholar
• Bisgaard H, Allen D, Milanowski J, et al. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics 2004;113:e87-94
   PubMed Web of Science ®Google Scholar
• Wasserman RL, Baker JW, Kim KT, et al. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study. Ann Allergy Asthma Immunol 2006;96:808-18
   PubMed Web of Science ®Google Scholar
• Chavasse RJ, Bastian-Lee Y, Richter H, et al. Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasone. Arch Dis Child 2001;5:143-8
   Google Scholar
• Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006;354:1985-97
   PubMed Web of Science ®Google Scholar
• Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics 2009;123:e519-25
   PubMed Web of Science ®Google Scholar
• Pao CS, McKenzie SA. Randomized controlled trial of fluticasone in preschool children with intermittent wheeze. Am J Respir Crit Care Med 2002;166:945-9
   PubMed Web of Science ®Google Scholar
• Murray CS, Woodcock A, Langley SJ, et al. Secondary prevention of asthma by the use of inhaled fluticasone propionate in wheezy infants (IFWIN): double-blind, randomised, controlled study. Lancet 2006;368:754-62
   PubMed Web of Science ®Google Scholar
• Singh SB, Weinberger MM, Zimmerman MB, Starner TD. Growth of preschool age children receiving daily inhaled corticosteroids. Allergy Asthma Proc 2013;34:511-18
   PubMedGoogle Scholar
• Bisgaard H. Systemic activity of inhaled topical steroid in toddlers studied by knemometry. Acta Paediatr 1993;82:1066-71
   PubMed Web of Science ®Google Scholar
• Anhøj J, Bisgaard AM, Bisgaard H. Systemic activity of inhaled steroids in 1- to 3-year-old children with asthma. Pediatrics 2002;109:E40
   PubMed Web of Science ®Google Scholar
• Pedersen S. Do inhaled corticosteroids inhibit growth in children? Am J Respir Crit Care Med 2001;164:521-35
   PubMed Web of Science ®Google Scholar
• Wilson N, Sloper K, Silverman M. Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children. Arch Dis Child 1995;72:317-20
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Hermansen MN, Loland L, et al. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006;354:1998-2005
   PubMed Web of Science ®Google Scholar
• Ducharme FM, Lemire C, Noya FJ, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med 2009;360:339-53
   PubMed Web of Science ®Google Scholar
• Panickar J, Lakhanpaul M, Lambert PC, et al. Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med 2009;360:329-38
   PubMed Web of Science ®Google Scholar
• Wilson NM, Silverman M. Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. Arch Dis Child 1990;65:407-10
   PubMed Web of Science ®Google Scholar
• Svedmyr J, Nyberg E, Thunqvist P, et al. Prophylactic intermittent treatment with inhaled corticosteroids of asthma exacerbations due to airway infections in toddlers. Acta Paediatr 1999;88:42-7
   PubMed Web of Science ®Google Scholar
• Connett G, Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide. Arch Dis Child 1993;68:85-7
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Mauger D, Bacharier LB, et al. Daily or intermittent budesonide in preschool children with recurrent wheezing. N Engl J Med 2011;365:1990-2001
   PubMed Web of Science ®Google Scholar
• Skoner DP, Greos LS, Kim KT, et al. Evaluation of the safety and efficacy of levalbuterol in 2-5-year-old patients with asthma. Pediatr Pulmonol 2005;40:477-86
   PubMed Web of Science ®Google Scholar
• Alario AJ, Lewander WJ, Dennehy P, et al. The efficacy of nebulized metaproterenol in wheezing infants and young children. Am J Dis Child 1992;146:412-18
   PubMedGoogle Scholar
• Kraemer R, Frey U, Sommer CW, Russi E. Short-term effect of albuterol, delivered via a new auxiliary device, in wheezy infants. Am Rev Respir Dis 1991;144:347-51
   PubMedGoogle Scholar
• Bentur L, Canny GJ, Shields MD, et al. Controlled trial of nebulized albuterol in children younger than 2 years of age with acute asthma. Pediatrics 1992;89:133-7
   PubMed Web of Science ®Google Scholar
• Sly PD, Lanteri CJ, Raven JM. Do wheezy infants recovering from bronchiolitis respond to inhaled salbutamol? Pediatr Pulmonol 1991;10:36-9
   PubMedGoogle Scholar
• Clarke JR, Aston H, Silverman M. Delivery of salbutamol by metered dose inhaler and valved spacer to wheezy infants: effect on bronchial responsiveness. Arch Dis Child 1993;69:125-9
   PubMedGoogle Scholar
• Hayden MJ, Wildhaber JH, LeSouef PN. Bronchodilator responsiveness testing using raised volume forced expiration in recurrently wheezing infants. Pediatr Pulmonol 1998;26:35-41
   PubMed Web of Science ®Google Scholar
• Chavasse RJ, Bastian-Lee Y, Richter H, et al. Inhaled salbutamol for wheezy infants: a randomised controlled trial. Arch Dis Child 2000;82:370-5
   PubMed Web of Science ®Google Scholar
• O'Callaghan C, Milner AD, Swarbrick A. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet 1986;2:1424-5
   PubMed Web of Science ®Google Scholar
• Prendiville A, Green S, Silverman M. Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves. Thorax 1987;42:86-91
   PubMed Web of Science ®Google Scholar
• Prendiville A, Rose A, Maxwell DL, Silverman M. Hypoxaemia in wheezy infants after bronchodilator treatment. Arch Dis Child 1987;62:997-1000
   PubMed Web of Science ®Google Scholar
• Hofhuis W, van der Wiel EC, Tiddens HA, et al. Bronchodilation in infants with malacia or recurrent wheeze. Arch Dis Child 2003;88:246-9
   PubMed Web of Science ®Google Scholar
• Chavasse RJPG, Seddon P, Bara A, McKean MC. Short acting beta2-agonists for recurrent wheeze in children under two years of age. Cochrane Database Syst Rev 2002;(3):CD002873
   Google Scholar
• Primhak RA, Smith CM, Yong SC, et al. The bronchoprotective effect of inhaled salmeterol in preschool children: a dose-ranging study. Eur Respir J 1999;13:78-81
   PubMedGoogle Scholar
• Nielsen KG, Bisgaard H. Bronchodilation and bronchoprotection in asthmatic preschool children from formoterol administered by mechanically actuated dry-powder inhaler and spacer. Am J Respir Crit Care Med 2001;164:256-9
   PubMedGoogle Scholar
• Plotnick LH, Ducharme FM. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev 2000;(4):CD000060
   Google Scholar
• Plotnick LH, Ducharme FM. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev 2013;8:CD000060
   Google Scholar
• Tenero L, Tezza G, Cattazzo E, Piacentini G. Wheezing in preschool children. Early Hum Dev 2013;89(Suppl 3):S13-17
   Google Scholar
• Singh RK, Tandon R, Dastidar SG, Ray A. A review on leukotrienes and their receptors with reference to asthma. J Asthma 2013;50:922-31
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Skoner D, Boza ML, et al. Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions. Pediatr Pulmonol 2009;44:568-79
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Zielen S, Garcia-Garcia ML, et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 2005;171:315-22
   PubMed Web of Science ®Google Scholar
• Robertson CF, Price D, Henry R, et al. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am J Respir Crit Care Med 2007;175:323-9
   PubMed Web of Science ®Google Scholar
• Bacharier LB, Phillips BR, Zeiger RS, et al. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol 2008;122:1127-35
   PubMed Web of Science ®Google Scholar
• Straub DA, Minocchieri S, Moeller A, et al. The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old. Chest 2005;27:509-14
   Google Scholar
• Kooi EM, Schokker S, Marike Boezen H, et al. Fluticasone or montelukast for preschool children with asthma-like symptoms: randomized controlled trial. Pulm Pharmacol Ther 2008;21:798-804
   PubMed Web of Science ®Google Scholar
• Atkinson TP. Is asthma an infectious disease? New evidence. Curr Allergy Asthma Rep 2013;13:702-9
   PubMed Web of Science ®Google Scholar
• Medina JL, Coalson JJ, Brooks EG, et al. Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation. Am J Respir Cell Mol Biol 2012;46:815-22
   PubMed Web of Science ®Google Scholar
• Esposito S, Blasi F, Arosio C, et al. Importance of acute mycoplasma pneumoniae and chlamydia pneumoniae infections in children with wheezing. Eur Respir J 2000;16:1142-6
   PubMed Web of Science ®Google Scholar
• Fonseca-Aten M, Okada PJ, Bowlware KL, et al. Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial. Ann Allergy Asthma Immunol 2006;97:457-63
   PubMed Web of Science ®Google Scholar
• Reiter J, Demirel N, Mendy A, et al. Macrolides for the long-term management of asthma – a meta-analysis of randomized clinical trials. Allergy 2013;68:1040-9
   PubMedGoogle Scholar
• van de Kant KD, Klaassen EM, Jöbsis Q, et al. Early diagnosis of asthma in young children by using non-invasive biomarkers of airway inflammation and early lung function measurements: study protocol of a case-control study. BMC Public Health 2009;9:210
   PubMed Web of Science ®Google Scholar
• Patria MF, Esposito S. Recurrent lower respiratory tract infections in children: a practical approach to diagnosis. Paediatr Respir Rev 2013;14:53-60
   PubMed Web of Science ®Google Scholar
• Just J, Gouvis-Echraghi R, Couderc R, et al. Novel severe wheezing young phenotypes: boys atopic multiple-trigger and girls nonatopic uncontrolled wheeze. J Allergy Clin Immunol 2012;130:103-10
   PubMed Web of Science ®Google Scholar
• Savanije OEM, Kerkhof M, Koppelman GH, Postma DS. Predicting who will have asthma at school age among preschool children. J Allergy Clin Immunol 2012;130:325-31
   PubMedGoogle Scholar